Residential treatment outcomes for adolescents with obsessive-compulsive disorder

Objective: We examined outcomes from a residential treatment program emphasizing exposure and response prevention (ERP) to determine if the typically robust response to this treatment in outpatient settings extends to patients treated in this unique context. Method: One hundred and seventy-two adole...

Full description

Saved in:
Bibliographic Details
Published inPsychotherapy research Vol. 26; no. 6; pp. 727 - 736
Main Authors Leonard, Rachel C., Franklin, Martin E., Wetterneck, Chad T., Riemann, Bradley C., Simpson, H. Blair, Kinnear, Kimberly, Cahill, Shawn P., Lake, Peter M.
Format Journal Article
LanguageEnglish
Published England Routledge 01.11.2016
Taylor & Francis Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective: We examined outcomes from a residential treatment program emphasizing exposure and response prevention (ERP) to determine if the typically robust response to this treatment in outpatient settings extends to patients treated in this unique context. Method: One hundred and seventy-two adolescents with primary Obsessive-compulsive disorder (OCD) completed measures at admission and discharge. Almost all (92.4%) participants had at least two diagnoses and nearly half (44.2%) had three or more. Treatment consisted of intensive ERP (i.e., approximately 26.5 hr per week), additional cognitive behavioral therapy interventions, and medication management within a residential setting. In contrast to the samples reported on in the vast majority of other pediatric OCD trials, participants in the current study were living apart from their families and were immersed within the treatment setting, with staff members available at all times. Results: Paired sample t-tests revealed significant decreases in OCD and depression severity. Conclusions: Results suggest that residential treatment for adolescents with OCD using a multimodal approach emphasizing ERP can be effective for complex cases with significant comorbidity. Results were comparable with several randomized controlled trials.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
simpson@nyspi.columbia.edu; phone: 646-774-7000.
kkinnear@rogershospital.org; phone: 1-800-767-4411.
cahill@uwm.edu; phone: 414-229-5099.
briemann@rogershospital.org; phone: 262-646-1388.
marty@mail.med.upenn.edu; phone: 215-746-1230.
plake@rogershospital.org; phone: 262-646-5268.
cwetterneck@rogershospital.org; phone: 262-646-1759.
ISSN:1050-3307
1468-4381
DOI:10.1080/10503307.2015.1065022